Micrima
Generated by Meeveem AI
"Redefining breast cancer diagnostics through personalised risk assessment and density measurement"
Bristol
•11 - 50 Employees
•Medical Devices
About Micrima
Micrima develops medical imaging technology that makes breast cancer screening safer and more accessible. The company's Mi~Scan system uses radio wave technology to measure breast tissue density without compression or radiation, addressing a gap for women with dense breasts who face up to six times higher cancer risk. Mi~Score combines this data with lifestyle and family history to deliver personalised risk profiles. The technology serves women of all ages, particularly younger women with denser tissue who often lack routine screening. By providing clear insights into breast density and cancer risk, Micrima empowers women to seek appropriate screening and catch cancer at stages where survival rates approach 100 percent.
30
Team Members
2005
Founded
Medical Devices
Sector
Hybrid
Work Environment
Our Vision
A world where every woman has access to personalised breast cancer risk assessment, enabling earlier detection and dramatically improving survival outcomes across all demographics.
Our Mission
At Micrima, our mission is to redefine breast cancer diagnostics by providing fast, personalised breast cancer risk and density scores for all women in any location.